Skip to content

What Is Ehlers-Danlos Misdiagnosed As? | Inciteful Med

Published: | Updated:

Ehlers-Danlos Syndrome (EDS) is most commonly misdiagnosed as fibromyalgia, anxiety, irritable bowel syndrome (IBS), or chronic fatigue syndrome. Doctors often misdiagnose EDS because they view systemic symptoms in isolation rather than recognizing an underlying connective tissue disorder.

Key Takeaways

  • Fibromyalgia is the most common misdiagnosis for EDS, but it does not account for joint hypermobility and severe tissue fragility.
  • Dysautonomia frequently co-occurs with EDS and can cause adrenaline surges that mimic severe anxiety or panic attacks.
  • Faulty collagen in the digestive tract causes motility issues that are often incorrectly diagnosed as Irritable Bowel Syndrome (IBS).
  • Patients wait an average of 10 to 22 years for an accurate EDS diagnosis due to doctors viewing systemic symptoms in isolation.
  • Bringing a completed 2017 hEDS Diagnostic Checklist to a doctor can help patients advocate for referrals to a geneticist or physiatrist.

If you have been told for years that your widespread pain, digestive issues, and fatigue are “just fibromyalgia,” “just anxiety,” or “all in your head,” you are not alone. Ehlers-Danlos Syndrome (EDS)—particularly the hypermobile subtype—is frequently misdiagnosed as fibromyalgia, Irritable Bowel Syndrome (IBS), or primary psychiatric conditions like anxiety and depression [1][2].

Because EDS causes systemic (whole-body) issues, patients frequently endure a grueling “diagnostic odyssey” that can last anywhere from 10 to 22 years before receiving an accurate diagnosis [3][4]. During this time, many patients experience medical gaslighting, where their severe, localized, or systemic symptoms are dismissed or minimized by healthcare providers [5][6]. This dismissal not only delays proper care but also takes a profound emotional toll on patients trying to find answers for their complex, unmanaged symptoms.

The Most Common Misdiagnoses

Because EDS is a connective tissue disorder, it affects collagen everywhere in the body—joints, skin, blood vessels, and organs. When doctors look at these symptoms in isolation rather than as a connected whole, they often arrive at incorrect diagnoses:

  • Fibromyalgia: This is the most common misdiagnosis for EDS [7]. Both conditions cause chronic, widespread pain and fatigue. However, fibromyalgia does not explain joint subluxations (partial dislocations), extreme joint hypermobility, or severe tissue fragility [8].
  • Anxiety, Depression, or Somatic Symptom Disorder: The constant adrenaline surges caused by dysautonomia (dysfunction of the autonomic nervous system, such as POTS), which frequently co-occurs with EDS, can mimic severe panic attacks or anxiety [1]. Furthermore, the distress of living with undiagnosed chronic pain is often wrongly labeled as the cause of the physical symptoms rather than the result of them [9].
  • Irritable Bowel Syndrome (IBS) and Functional Dyspepsia: Gastrointestinal issues are highly prevalent in EDS. Doctors often diagnose IBS because they fail to recognize that the stretchy, faulty collagen in the digestive tract is actually causing motility issues and reflux [10][11].
  • Chronic Fatigue Syndrome (ME/CFS): The crushing fatigue resulting from poor sleep, chronic pain, and a nervous system in overdrive often leads to a CFS diagnosis while missing the underlying structural connective tissue defect [12]. It is important to note that while EDS fatigue is often misdiagnosed as ME/CFS, the two conditions can frequently co-occur. True ME/CFS features severe post-exertional malaise (PEM), which requires specific management strategies [12].

Diagnostic Challenges Across EDS Subtypes

While there are 13 subtypes of EDS, they present differently and face unique diagnostic hurdles. Understanding these differences can help clarify why a diagnosis might be missed:

  • Hypermobile EDS (hEDS): This is the most common subtype and lacks an identified genetic biomarker, meaning it must be diagnosed clinically [8]. Because there is no simple blood test, hEDS is the subtype most frequently dismissed as fibromyalgia or anxiety [13]. Note: Patients who do not fully meet the rigorous 2017 hEDS criteria may be diagnosed with Hypermobility Spectrum Disorder (HSD). HSD is managed almost identically to hEDS, so receiving an HSD diagnosis is not a “failed” evaluation [3].
  • Classical EDS (cEDS) & Classical-like EDS (clEDS): These subtypes feature highly stretchy, doughy skin and severe scarring. They are sometimes dismissed as mere clumsiness, normal childhood bruising, or isolated dermatological conditions [14][15].
  • Vascular EDS (vEDS): Characterized by severe, life-threatening fragility of blood vessels and organs, vEDS might go completely undetected until a catastrophic event, such as an arterial rupture or hollow organ perforation, occurs [16][17].
  • Spondylodysplastic (spEDS) & Dermatosparaxis (dEDS): These are exceptionally rare. spEDS features severe musculoskeletal issues like short stature and limb deformities [18], while dEDS is characterized by extreme skin fragility [19]. They are sometimes miscategorized as other rare genetic or autoimmune disorders until specific molecular genetic testing is performed [20].

How to Advocate for an EDS Evaluation

If you suspect your current diagnoses do not fully explain your symptoms, you must often become your own medical advocate. Here are actionable steps to help you push for a comprehensive EDS evaluation:

  1. Print the 2017 hEDS Diagnostic Checklist: The Ehlers-Danlos Society provides a standardized clinical checklist used to diagnose hEDS [8]. Print this document, read through it, and estimate your Beighton Score for joint hypermobility to bring to your appointment. (Safety warning: Do not force or push your joints into painful subluxations just to test your score). This checklist provides a structured, objective framework that doctors respect.
  2. Keep a Systemic Symptom Log: Stop talking about symptoms in isolation. Keep a detailed log showing how your joint pain, gastrointestinal issues, dizziness upon standing, and skin issues happen concurrently. Tracking comorbidities like POTS and MCAS helps clinicians recognize the multisystemic “neuroconnective phenotype” rather than isolated complaints [1][21].
  3. Request the Right Referrals: Primary care doctors often lack the specialized training required to confidently diagnose EDS [13]. Specifically ask for a referral to:
    • A Medical Geneticist: To perform molecular testing to rule out vEDS, cEDS, and other rare connective tissue disorders. Note: Waitlists for medical geneticists can be 1 to 2 years long, so it is best to get on the list as early as possible.
    • Physical Medicine and Rehabilitation (PM&R) / Physiatry: These specialists focus on restoring function and often understand joint hypermobility well.
    • An EDS-Literate Rheumatologist: Be cautious with standard rheumatologists; many reject hEDS referrals because it is a structural, rather than autoimmune, condition [22][4]. Ensure the doctor specifically mentions hypermobility in their practice.
    • Dysautonomia Specialists: Sometimes, working with a cardiologist or neurologist familiar with POTS and MCAS can open the door, as they often recognize the EDS “trifecta” (EDS, POTS, MCAS).

If a doctor refuses your referral request, ask them to explain their differential diagnosis or ask what specific clinical signs would warrant a referral in the future.

Frequently Asked Questions

Why is Ehlers-Danlos Syndrome commonly misdiagnosed as fibromyalgia?
Both conditions cause chronic widespread pain and fatigue. However, fibromyalgia does not explain the extreme joint hypermobility, frequent partial dislocations, and severe tissue fragility that are hallmark signs of EDS.
Can EDS be misdiagnosed as anxiety or depression?
Yes. The constant adrenaline surges from dysautonomia, which frequently co-occurs with EDS, can mimic severe panic attacks or anxiety. Additionally, the emotional distress of living with undiagnosed chronic pain is often wrongly labeled as the cause of physical symptoms rather than the result of them.
Why do doctors often misdiagnose EDS digestive issues as IBS?
Gastrointestinal issues are prevalent in EDS due to faulty, stretchy collagen in the digestive tract causing motility issues and reflux. Doctors often diagnose IBS because they view the digestive symptoms in isolation rather than as part of a systemic connective tissue disorder.
How can I advocate for an accurate EDS evaluation?
You can keep a detailed log of all your systemic symptoms to show how your joint pain, digestive issues, and dizziness happen concurrently. You can also print the 2017 hEDS Diagnostic Checklist, estimate your Beighton Score, and bring it to your doctor to request a specialized referral.
What kind of doctor should I see for an Ehlers-Danlos diagnosis?
A medical geneticist is often needed to perform molecular testing to rule out rare EDS subtypes. Physical Medicine and Rehabilitation doctors and EDS-literate rheumatologists who specialize in joint hypermobility can also properly evaluate and manage the condition.

Questions for Your Doctor

  • Given my widespread pain and history of joint issues, how can we differentiate whether I have fibromyalgia or an underlying connective tissue disorder like Ehlers-Danlos Syndrome?
  • I have tracked my symptoms and see a pattern involving my joints, digestion, and dizziness upon standing. Could these be connected rather than isolated conditions?
  • What specific symptoms or clinical signs would warrant a referral to a geneticist or a physiatrist for a hypermobility evaluation?
  • I have completed the 2017 hEDS diagnostic checklist based on my symptom history. Can we review it together to determine if I meet the clinical criteria?
  • If you do not feel comfortable evaluating connective tissue disorders, can you refer me to a specialist, such as an EDS-literate physical medicine and rehabilitation (PM&R) doctor or geneticist, who can?

Questions for You

  • Have I been treating my joint pain, digestive problems, and fatigue as separate issues, and could they be related to a single systemic condition?
  • Are there specific joints that consistently pop out of place or cause me pain, and do they align with the Beighton Score criteria?
  • How long have I been seeking answers for my symptoms, and have any blood relatives experienced similar 'unexplained' medical issues or extreme flexibility?
  • Do I notice sudden surges in heart rate, dizziness, or 'anxiety-like' adrenaline symptoms specifically when I stand up or change positions?

Want personalized information?

Type your question below to get evidence-based answers tailored to your situation.

References

  1. 1

    Idiopathic osteoporosis, Ehlers-Danlos syndrome, postural orthostatic tachycardia syndrome, and mast cell activation disorder in a 27-year-old male patient: A unique case presentation.

    Rattray C

    Clinical case reports 2022; (10(5)):e05887 doi:10.1002/ccr3.5887.

    PMID: 35600027
  2. 2

    An overview of Ehlers Danlos syndrome and the link between postural orthostatic tachycardia syndrome and gastrointestinal symptoms with a focus on gastroparesis.

    Wu W, Ho V

    Frontiers in neurology 2024; (15()):1379646 doi:10.3389/fneur.2024.1379646.

    PMID: 39268060
  3. 3

    Comorbidity, misdiagnoses, and the diagnostic odyssey in patients with hypermobile Ehlers-Danlos syndrome.

    Halverson CME, Cao S, Perkins SM, Francomano CA

    Genetics in medicine open 2023; (1(1)):100812 doi:10.1016/j.gimo.2023.100812.

    PMID: 39669244
  4. 4

    The GoodHope Ehlers Danlos Syndrome Clinic: development and implementation of the first interdisciplinary program for multi-system issues in connective tissue disorders at the Toronto General Hospital.

    Mittal N, Mina DS, McGillis L, et al.

    Orphanet journal of rare diseases 2021; (16(1)):357 doi:10.1186/s13023-021-01962-7.

    PMID: 34376220
  5. 5

    Healthcare experiences among adults with hypermobile Ehlers-Danlos syndrome and hypermobility spectrum disorder in the United States.

    Estrella E, Frazier PA

    Disability and rehabilitation 2024; (46(4)):731-740 doi:10.1080/09638288.2023.2176554.

    PMID: 36772820
  6. 6

    Patients with Ehlers-Danlos syndrome on the diagnostic odyssey: Rethinking complexity and difficulty as a hero's journey.

    Halverson CME, Clayton EW, Garcia Sierra A, Francomano C

    American journal of medical genetics. Part C, Seminars in medical genetics 2021; (187(4)):416-424 doi:10.1002/ajmg.c.31935.

    PMID: 34524722
  7. 7

    Central sensitization as the mechanism underlying pain in joint hypermobility syndrome/Ehlers-Danlos syndrome, hypermobility type.

    Di Stefano G, Celletti C, Baron R, et al.

    European journal of pain (London, England) 2016; (20(8)):1319-25 doi:10.1002/ejp.856.

    PMID: 26919608
  8. 8

    Updates in Clinical and Genetics Aspects of Hypermobile Ehlers Danlos Syndrome

    Forghani I

    Balkan medical journal 2019; (36(1)):12-16 doi:10.4274/balkanmedj.2018.1113.

    PMID: 30063214
  9. 9

    Is the Pain Just Physical? The Role of Psychological Distress, Quality of Life, and Autistic Traits in Ehlers-Danlos Syndrome, an Internet-Based Survey in Italy.

    Rocchetti M, Bassotti A, Corradi J, et al.

    Healthcare (Basel, Switzerland) 2021; (9(11)) doi:10.3390/healthcare9111472.

    PMID: 34828519
  10. 10

    A machine learning approach to stratify patients with hypermobile Ehlers-Danlos syndrome/hypermobility spectrum disorders according to disorders of gut brain interaction, comorbidities and quality of life.

    Choudhary A, Fikree A, Ruffle JK, et al.

    Neurogastroenterology and motility 2025; (37(1)):e14957 doi:10.1111/nmo.14957.

    PMID: 39543811
  11. 11

    Ehlers-Danlos Syndrome-Hypermobility Type: A Much Neglected Multisystemic Disorder.

    Gazit Y, Jacob G, Grahame R

    Rambam Maimonides medical journal 2016; (7(4)) doi:10.5041/RMMJ.10261.

    PMID: 27824552
  12. 12

    Psychosocial Influence of Ehlers-Danlos Syndrome in Daily Life of Patients: A Qualitative Study.

    Palomo-Toucedo IC, Leon-Larios F, Reina-Bueno M, et al.

    International journal of environmental research and public health 2020; (17(17)) doi:10.3390/ijerph17176425.

    PMID: 32899328
  13. 13

    Understanding the issues of hypermobility spectrum disorders and hypermobile Ehlers-Danlos syndrome in primary care: a qualitative integrative review.

    Jones E, Carrieri D

    Disability and rehabilitation 2025; 1-16 doi:10.1080/09638288.2025.2517246.

    PMID: 40534133
  14. 14

    The detailed obstetric course of the first Japanese patient with AEBP1-related Ehlers-Danlos syndrome (classical-like EDS, type 2).

    Sanai H, Nakamura Y, Koike Y, et al.

    The journal of obstetrics and gynaecology research 2023; (49(3)):1043-1047 doi:10.1111/jog.15541.

    PMID: 36600409
  15. 15

    Clinical and Molecular Characterization of Classical-Like Ehlers-Danlos Syndrome Due to a Novel TNXB Variant.

    Rymen D, Ritelli M, Zoppi N, et al.

    Genes 2019; (10(11)) doi:10.3390/genes10110843.

    PMID: 31731524
  16. 16

    Efficacy of Irbesartan in Celiprolol-Treated Patients With Vascular Ehlers-Danlos Syndrome.

    Jeunemaitre X, Mousseaux E, Frank M, et al.

    Circulation 2025; (151(10)):686-695 doi:10.1161/CIRCULATIONAHA.124.072849.

    PMID: 39906986
  17. 17

    Pediatric Innominate Artery Pseudoaneurysm Rupture in Vascular Ehlers-Danlos Syndrome: A Case Report.

    Vos A, Burns KM

    Clinical practice and cases in emergency medicine 2021; (5(2)):226-229 doi:10.5811/cpcem.2021.3.51787.

    PMID: 34437011
  18. 18

    Report of two siblings with spondylodysplastic Ehlers-Danlos syndrome and B4GALT7 deficiency.

    Lorenz D, Kress W, Zaum AK, et al.

    BMC pediatrics 2021; (21(1)):293 doi:10.1186/s12887-021-02767-0.

    PMID: 34193099
  19. 19

    Genetic diagnosis of the Ehlers-Danlos syndromes.

    Zschocke J, Demirdas S, van Dijk FS

    Medizinische Genetik : Mitteilungsblatt des Berufsverbandes Medizinische Genetik e.V 2024; (36(4)):235-245 doi:10.1515/medgen-2024-2061.

    PMID: 39629471
  20. 20

    Differences in manifestations of Marfan syndrome, Ehlers-Danlos syndrome, and Loeys-Dietz syndrome.

    Meester JAN, Verstraeten A, Schepers D, et al.

    Annals of cardiothoracic surgery 2017; (6(6)):582-594 doi:10.21037/acs.2017.11.03.

    PMID: 29270370
  21. 21

    AGA Clinical Practice Update on GI Manifestations and Autonomic or Immune Dysfunction in Hypermobile Ehlers-Danlos Syndrome: Expert Review.

    Aziz Q, Harris LA, Goodman BP, et al.

    Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association 2025; (23(8)):1291-1302 doi:10.1016/j.cgh.2025.02.015.

    PMID: 40387691
  22. 22

    [Up-to-date classification and multidisciplinary symptoms of Ehlers-Danlos syndromes].

    Ralovich FV, Kiss N, Horváth K, et al.

    Orvosi hetilap 2019; (160(16)):603-612 doi:10.1556/650.2019.31351.

    PMID: 30983397

This page provides information on Ehlers-Danlos Syndrome misdiagnoses for educational purposes only and does not constitute medical advice. Always consult your healthcare provider or a medical geneticist for an accurate diagnosis and treatment plan.

Stay up to date

Get notified when new research about Ehlers Danlos Syndrome (EDS) is published.

No spam. Unsubscribe anytime.